A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
暂无分享,去创建一个
R. Lange | H. Schunkert | F. Mohr | A. Kastrati | T. Walther | M. Misfeld | A. Boening | C. Hamm | G. Laufer | P. Radke | U. Zeymer | M. Siepe | F. Beyersdorf | S. Sandner | H. Sievers | D. Hammel | R. Schulz | B. Danner | M. Schmoeckel | C. Knosalla | Antoinette de Waha | J. Cremer | F. Schöndube | T. Fischlein | F. Schönrath | R. Hambrecht | T. Attmann | M. von Scheidt | K. Koch-Buettner | G. Goerlach | M. Oberhoffer | T. Ziegelhöffer | A. Joost | Léon M. Putman